{"id":"https://openalex.org/W2890956331","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.8032","title":"Phase I venetoclax monotherapy for relapsed/refractory multiple myeloma.","display_name":"Phase I venetoclax monotherapy for relapsed/refractory multiple myeloma.","publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W2890956331","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.8032","mag":"2890956331"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.34.15_suppl.8032","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.8032","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.8032","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026574827","display_name":"Shaji Kunnathu Kumar","orcid":"https://orcid.org/0000-0001-5392-9284","observed_orcids":["https://orcid.org/0000-0001-5392-9284"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaji Kumar","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026151069","display_name":"Ravi Vij","orcid":"https://orcid.org/0000-0001-8795-3610","observed_orcids":["https://orcid.org/0000-0001-8795-3610"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ravi Vij","raw_affiliation_strings":["Washington University School of Medicine, St. Louis, MO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, St. Louis, MO;","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077897003","display_name":"Jonathan L. Kaufman","orcid":"https://orcid.org/0000-0002-5687-6429","observed_orcids":["https://orcid.org/0000-0002-5687-6429"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan L. Kaufman","raw_affiliation_strings":["Winship Cancer Institute of Emory University, Atlanta, GA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute of Emory University, Atlanta, GA;","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058598134","display_name":"Joseph R Mikhael","orcid":"https://orcid.org/0000-0001-9670-2864","observed_orcids":["https://orcid.org/0000-0001-9670-2864"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Mikhael","raw_affiliation_strings":["Mayo Clinic, Scottsdale, AZ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Scottsdale, AZ;","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024315315","display_name":"Thierry T.F. Facon","orcid":"https://orcid.org/0000-0001-7705-8460","observed_orcids":["https://orcid.org/0000-0001-7705-8460"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thierry Facon","raw_affiliation_strings":["Service des Maladies du Sang Place de Verdun, Lille, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service des Maladies du Sang Place de Verdun, Lille, France;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059590275","display_name":"Brigitte Pegouri\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800555055","display_name":"Centre Hospitalier Universitaire de Grenoble","ror":"https://ror.org/041rhpw39","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I2800555055"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Brigitte Pegourie","raw_affiliation_strings":["University Hospital, Grenoble, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital, Grenoble, France;","institution_ids":["https://openalex.org/I2800555055"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070014603","display_name":"Lotfi Benboubker","orcid":"https://orcid.org/0000-0003-0167-8836","observed_orcids":["https://orcid.org/0000-0003-0167-8836"]},"institutions":[{"id":"https://openalex.org/I4210095477","display_name":"Centre Hospitalier Universitaire de Tours","ror":"https://ror.org/00jpq0w62","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210095477"]},{"id":"https://openalex.org/I4210100159","display_name":"H\u00f4pital Bretonneau","ror":"https://ror.org/0146pps37","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210100159"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lotfi Benboubker","raw_affiliation_strings":["Centre Hospitalier Universitaire Tours-Hopital Bretonneau, Tours, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Universitaire Tours-Hopital Bretonneau, Tours, France;","institution_ids":["https://openalex.org/I4210095477","https://openalex.org/I4210100159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033550793","display_name":"Cristina Gasparetto","orcid":"https://orcid.org/0000-0003-1513-5605","observed_orcids":["https://orcid.org/0000-0003-1513-5605"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cristina Gasparetto","raw_affiliation_strings":["Duke University Medical Center, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC;","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003041443","display_name":"Martine Amiot","orcid":"https://orcid.org/0000-0003-0428-7355","observed_orcids":["https://orcid.org/0000-0003-0428-7355"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Martine Amiot","raw_affiliation_strings":["CHU de Nantes, Hotel Dieu\u2014HME, Nantes, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU de Nantes, Hotel Dieu\u2014HME, Nantes, France;","institution_ids":["https://openalex.org/I3019204325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103143602","display_name":"Philippe Moreau","orcid":"https://orcid.org/0000-0003-1780-8746","observed_orcids":["https://orcid.org/0000-0003-1780-8746"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Moreau","raw_affiliation_strings":["CHU de Nantes, Hotel Dieu\u2014HME, Nantes, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU de Nantes, Hotel Dieu\u2014HME, Nantes, France;","institution_ids":["https://openalex.org/I3019204325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008924066","display_name":"Susan Diehl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Diehl","raw_affiliation_strings":["AbbVie, Inc, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Inc, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014949434","display_name":"Stefanie Alzate","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefanie Alzate","raw_affiliation_strings":["AbbVie, Inc, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Inc, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057862805","display_name":"Jeremy A. Ross","orcid":"https://orcid.org/0000-0002-8458-7819","observed_orcids":["https://orcid.org/0000-0002-8458-7819"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy A Ross","raw_affiliation_strings":["AbbVie, Inc, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Inc, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009328862","display_name":"Martin Dunbar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin Dunbar","raw_affiliation_strings":["AbbVie, Inc, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Inc, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085546073","display_name":"Ming Zhu","orcid":"https://orcid.org/0000-0003-0221-2325","observed_orcids":["https://orcid.org/0000-0003-0221-2325"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ming Zhu","raw_affiliation_strings":["AbbVie, Inc, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Inc, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Suresh K Agarwal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suresh K Agarwal","raw_affiliation_strings":["AbbVie, Inc, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Inc, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088427493","display_name":"Joel D. Leverson","orcid":"https://orcid.org/0000-0003-1162-724X","observed_orcids":["https://orcid.org/0000-0003-1162-724X"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel Leverson","raw_affiliation_strings":["AbbVie, Inc, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Inc, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089774924","display_name":"Paulo Maciag","orcid":"https://orcid.org/0000-0003-1172-9772","observed_orcids":["https://orcid.org/0000-0003-1172-9772"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paulo Cesar Maciag","raw_affiliation_strings":["AbbVie, Inc, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Inc, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113792916","display_name":"Maria E. Verdugo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria E. Verdugo","raw_affiliation_strings":["AbbVie, Inc, North Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, Inc, North Chicago, IL;","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058940187","display_name":"Cyrille Touzeau","orcid":"https://orcid.org/0000-0003-0275-2575","observed_orcids":["https://orcid.org/0000-0003-0275-2575"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Cyrille Touzeau","raw_affiliation_strings":["CHU de Nantes, Hotel Dieu\u2014HME, Nantes, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU de Nantes, Hotel Dieu\u2014HME, Nantes, France;","institution_ids":["https://openalex.org/I3019204325"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"15_suppl","first_page":"8032","last_page":"8032"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9980000257492065},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.9470000267028809},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.7699999809265137},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.703000009059906},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7900000214576721},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":0.628000020980835},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6159999966621399},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.335999995470047},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.42399999499320984},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5419999957084656},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5109999775886536},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.6669999957084656},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.5479999780654907},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4399999976158142},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.5709999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8806871175765991},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6773364543914795},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6553208827972412},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.6020597219467163},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5979399085044861},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5730424523353577},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.5588663816452026},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.506890594959259},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.48951852321624756},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.4573360085487366},{"id":"https://openalex.org/C9583187","wikidata":"https://www.wikidata.org/wiki/Q7919510","display_name":"Ven","level":2,"score":0.450494647026062},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.4369061589241028},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.4335087835788727},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.39055097103118896},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.2656393051147461},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.20259380340576172},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2016.34.15_suppl.8032","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.8032","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.8032","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8600000143051147}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2108932646","https://openalex.org/W2102372291","https://openalex.org/W2243375749","https://openalex.org/W2400769328","https://openalex.org/W2890830722","https://openalex.org/W2806380367","https://openalex.org/W3216460348","https://openalex.org/W3197688599","https://openalex.org/W3214399270","https://openalex.org/W2343244371"],"abstract_inverted_index":{"8032":[0],"Background:":[1],"The":[2],"anti-apoptotic":[3],"protein":[4],"BCL-2":[5,24,43],"has":[6,309,406],"been":[7],"implicated":[8],"in":[9,30,57,85,93,144,159,169,314,328,332],"the":[10],"survival":[11],"of":[12,54,99,147,210,273,408],"multiple":[13],"myeloma":[14],"(MM)":[15],"cells.":[16],"Venetoclax":[17],"(VEN)":[18],"is":[19],"an":[20],"oral,":[21],"highly":[22],"selective":[23],"inhibitor,":[25],"which":[26],"induces":[27],"cell":[28,32],"death":[29,222],"MM":[31],"lines":[33],"and":[34,44,68,90,107,135,182,258,291,321],"primary":[35],"samples,":[36],"particularly":[37],"those":[38],"with":[39,251,411],"t(11;14),":[40],"a":[41,310],"high":[42],"low":[45],"BCL-XL":[46],"profile.":[47],"Methods:":[48],"In":[49,281],"this":[50,329],"phase":[51],"1":[52,219,232,235,359,372,377,380,399,401],"study":[53],"VEN":[55,74,190,307,324],"monotherapy":[56,308],"relapsed/refractory":[58],"(R/R)":[59],"MM,":[60],"objectives":[61],"are":[62],"to":[63,202,206,221],"evaluate":[64],"safety,":[65],"PK,":[66],"RPTD,":[67],"preliminary":[69],"efficacy.":[70],"After":[71],"2-week":[72],"dose-ramp-up,":[73],"was":[75,112,191,246,298],"given":[76],"daily":[77],"at":[78,242,263],"300,":[79],"600,":[80],"900,":[81],"or":[82],"1200":[83,91,304],"mg":[84,92,244,268],"dose":[86],"escalation":[87],"(DE)":[88],"cohorts":[89],"safety":[94,312],"expansion":[95],"(SE).":[96],"Results:":[97],"As":[98],"9/17/15,":[100],"48":[101,274],"pts":[102,140,148,172,197,275],"were":[103,115,149,173,240,260,276,285],"enrolled:":[104],"30":[105],"DE":[106],"18":[108,139,394],"SE.":[109],"Median":[110,119,186],"age":[111],"65;":[113],"28":[114],"ISS":[116],"stage":[117],"II/III.":[118],"(range)":[120,187],"prior":[121,127],"therapies:":[122],"5":[123,227,361,383],"(1\u201315).":[124],"45":[125],"had":[126,137,141],"bortezomib":[128],"(32":[129],"refractory),":[130,134],"46":[131],"lenalidomide":[132],"(37":[133],"40":[136],"SCT.":[138],"t(11;14).":[142],"AEs":[143,158,207],"\u2265":[145,160,170],"30%":[146],"diarrhea":[150],"(40%),":[151,153],"nausea":[152,250],"thrombocytopenia":[154,162],"(31%).":[155],"Grade":[156],"3/4":[157],"10%:":[161],"(29%),":[163],"anemia,":[164],"neutropenia":[165],"(17%":[166],"each).":[167,185],"SAEs":[168],"2":[171,216,238,364,367,370,403],"sepsis":[174],"(n":[175,269,344,349,353],"=":[176,270,345,350,354],"3),":[177],"cough,":[178],"malignant":[179],"neoplasm":[180],"progression,":[181],"pyrexia":[183],"(2":[184],"time":[188],"on":[189],"1.9":[192],"(0.2\u201313.8)":[193],"months.":[194],"33":[195],"(69%)":[196],"discontinued":[198],"(DC):":[199],"26":[200],"related":[201],"PD,":[203,231],"4":[204,357],"due":[205,220],"(worsening":[208],"shortness":[209],"breath,":[211],"hypokalemia,":[212],"nausea,":[213],"lung":[214,236],"disorder),":[215],"withdrew":[217],"consent,":[218],"(brain":[223],"hemorrhage":[224],"following":[225],"injury).":[226],"deaths":[228],"occurred":[229],"(3":[230],"brain":[233],"hemorrhage,":[234],"disorder).":[237],"DLTs":[239],"seen":[241],"600":[243],"(cohort":[245],"expanded):":[247],"epigastric":[248],"pain,":[249],"abdominal":[252],"pain.":[253],"Steady":[254],"state":[255],"mean":[256],"Cmax":[257],"AUC24":[259],"~dose":[261],"proportional":[262],"all":[264,303],"doses":[265],"except":[266],"900":[267],"21).":[271],"43":[272],"evaluable":[277],"for":[278,287,300],"efficacy":[279],"(table).":[280],"CR":[282,363],"pts,":[283,302],"responses":[284],"maintained":[286],"9.7":[288],"(600":[289],"mg)":[290],"9.0":[292],"months":[293],"(900":[294],"mg,":[295],"ongoing).":[296],"VGPR":[297,369],"reported":[299],"3":[301,374],"mg.":[305],"Conclusions:":[306],"tolerable":[311],"profile":[313],"R/R":[315],"MM.":[316],"Preliminary":[317],"efficacy,":[318],"including":[319],"CR,":[320],"VGPR,":[322],"support":[323],"single":[325],"agent":[326],"activity":[327],"population,":[330],"primarily":[331],"t(11;14)":[333,343,348],"pts.":[334],"Clinical":[335],"trial":[336],"information:":[337],"NCT01794520.Best":[338],"response,":[339],"n":[340],"(%)":[341],"With":[342],"17)":[346],"Without":[347],"26)":[351],"All":[352],"43)":[355],"ORR":[356],"(24)":[358],"(4)":[360,402],"(12)":[362,365,371],"0":[366,379],"(5)":[368,404],"(4)*":[373],"(7)":[375],"MR":[376],"(6)":[378,400],"(2)":[381],"SD":[382],"(29)":[384],"12":[385,392],"(46)":[386,393],"17":[387],"(40)":[388],"PD":[389],"6":[390],"(35)":[391],"(42)":[395],"DC":[396],"before":[397],"assessment":[398],"*Pt":[405],"translocation":[407],"chromosome":[409],"14":[410],"unknown":[412],"partner":[413]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}